VRTX Oct 2024 550.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 2.0000 |
| Open | 2.0000 |
| Bid | 0.0000 |
| Ask | 2.7000 |
| Strike | 550.00 |
| Expiry date | 2024-10-18 |
| Day's range | 2.0000 - 2.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 12 |
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Investor's Business DailyDow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.
© 2024 Yahoo. All rights reserved.